Novo Nordisk Pharma Sp.z.o.o

Last updated: 13.02.2014

Address: ul. 17 January 45 B ,02-146 Warsaw

Tel: (+48 22) 44 44 900


Company description

Novo Nordisk is a global healthcare company with 87 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.

Headquartered in Denmark, Novo Nordisk employs more than 29,300 employees in 76 countries, and markets its products in 179 countries.

Novo Nordisk’s B shares are listed on the NASDAQ OMX Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO).

Products and services

Therapy areas and products

Diabetes care
Haemostasis management
Hormone replacement therapy
Growth hormone therapy


We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here